The Natural History of Cervical Intraepithelial Neoplasia Grades 1, 2, and 3: A Systematic Review and Meta-analysis

医学 荟萃分析 自然史 宫颈上皮内瘤变 梅德林 妇科 内科学 宫颈癌 肿瘤科 癌症 政治学 法学
作者
Diede Loopik,Heidi A. Bentley,Maria N. Eijgenraam,Joanna IntHout,Ruud L.M. Bekkers,J. Bentley
出处
期刊:Journal of Lower Genital Tract Disease [Lippincott Williams & Wilkins]
卷期号:25 (3): 221-231 被引量:84
标识
DOI:10.1097/lgt.0000000000000604
摘要

The aim of the study was to obtain an updated overview of regression, persistence, and progression rates of conservatively managed cervical intraepithelial neoplasia grade 1 (CIN 1)/CIN 2/CIN 3.Data sources were MEDLINE, Embase, and Cochrane (January 1, 1973-April 14, 2020). Two reviewers extracted data and assessed risk of bias. To estimate outcome rates, we pooled proportions of the individual study results using random-effects meta-analysis, resulting in point estimates and corresponding 95% CIs. Heterogeneity was quantified by the I2 and τ2 measures.Eighty-nine studies were included, 63 studies on CIN 1 (n = 6,080-8,767), 42 on CIN 2 (n = 2,909-3,830), and 7 on CIN 3 (n = 245-351). The overall regression, persistence, and progression to CIN 2 or worse and CIN 3 or worse rates for women with conservatively managed CIN 1 were 60% (95% CI = 55-65, I2 = 92%), 25% (95% CI = 20-30, I2 = 94%), 11% (95% CI = 8-13, I2 = 89%), and 2% (95% CI = 1-3, I2 = 82%), respectively. The overall regression, persistence, and progression rates for CIN 2 were 55% (95% CI = 50-60, I2 = 85%), 23% (95% CI = 19-28, I2 = 83%), and 19% (95% CI = 15-23, I2 = 88%), respectively. Finally, for CIN 3, these were 28% (95% CI = 17-41, I2 = 68%), 67% (95% CI = 36-91, I2 = 84%), and 2% (95% CI = 0-25, I2 = 95%), respectively. Cervical intraepithelial neoplasia grade 2 regression was significantly higher in women 30 years or younger and high-risk human papillomavirus-negative women (66%, 95% CI = 62-70, I2 = 76%; 94%, 95% CI = 84-99, I2 = 60%). Only 2/7,180 (0.03%) and 10/3,037 (0.3%) of the CIN 1 and CIN 2 cases progressed to cervical cancer.Most CIN 1/CIN 2 will regress spontaneously in less than 24 months, with the highest rates in high-risk human papillomavirus-negative and young women, whereas progression to cancer is less than 0.5%. Conservative management should be considered, especially in fertile women and with expected high compliance. Given the heterogeneity in regression rates of high-grade histology, this should be classified as CIN 2 or CIN 3 to guide management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
陶醉的又夏完成签到 ,获得积分10
刚刚
YL完成签到,获得积分10
刚刚
刚刚
刚刚
yehaidadao完成签到,获得积分10
1秒前
加减乘除完成签到,获得积分10
1秒前
大胆的忆寒完成签到,获得积分10
3秒前
3秒前
麦当劳信徒完成签到,获得积分10
3秒前
高大威猛小帅完成签到 ,获得积分10
4秒前
lime完成签到,获得积分10
4秒前
韩哈哈完成签到,获得积分10
4秒前
牟翎完成签到,获得积分10
4秒前
今后应助合适的梦菡采纳,获得10
4秒前
又见白龙完成签到,获得积分10
6秒前
超帅含烟发布了新的文献求助10
7秒前
sugar完成签到,获得积分10
8秒前
小鱼完成签到,获得积分10
9秒前
康轲完成签到,获得积分10
10秒前
海东来完成签到,获得积分10
10秒前
Disci完成签到,获得积分10
11秒前
Joeswith完成签到,获得积分10
13秒前
务实的奇迹完成签到 ,获得积分10
14秒前
Yixuan_Zou完成签到,获得积分10
16秒前
dunhuang完成签到,获得积分10
16秒前
mgr完成签到,获得积分10
16秒前
hanyingwang完成签到,获得积分10
17秒前
zhangxin150完成签到,获得积分10
17秒前
MrCoolWu完成签到,获得积分10
18秒前
just完成签到,获得积分10
18秒前
闫栋完成签到 ,获得积分10
20秒前
bigfish完成签到,获得积分10
20秒前
stop here完成签到,获得积分10
21秒前
陶军辉完成签到 ,获得积分10
22秒前
22秒前
22秒前
yuhang zhu完成签到,获得积分10
23秒前
12we完成签到 ,获得积分10
23秒前
健壮的鸽子完成签到,获得积分10
23秒前
爆米花应助Yixuan_Zou采纳,获得10
23秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968578
求助须知:如何正确求助?哪些是违规求助? 3513406
关于积分的说明 11167631
捐赠科研通 3248853
什么是DOI,文献DOI怎么找? 1794499
邀请新用户注册赠送积分活动 875150
科研通“疑难数据库(出版商)”最低求助积分说明 804671